How to Submit an R&D Tax Credit Claim to HMRC: A Step-by-Step Guide for 2026–27
Here's a number that should give every claimant pause: R&D tax credit enquiries from HMRC now touch around one in five claims, up from roughly one in twenty just a few years ago. That's a fivefold jump in scrutiny in a remarkably short space of time. HMRC didn't do this on a whim — it followed genuine, widespread abuse of the scheme, and the crackdown has worked, with the estimated error and fraud rate falling from 16.7% to under 6% over the same period. But here's the catch: that crackdown doesn't just catch the chancers. It catches genuine, honest claimants who simply didn't know the rules had moved.
I've sat across the table from more than one business owner in Kent who was baffled to receive an enquiry letter, convinced their claim was watertight because it "looked the same as last year's." The trouble is, last year's rules often aren't this year's rules anymore. R&D tax relief has been through more change in the past three years than in the previous decade combined — a merged scheme, a new intensive support route for loss-making SMEs, tighter overseas restrictions, and two entirely new mandatory forms. Get any one of these wrong, and you're not just risking a delay. You're risking a formal compliance check that can drag on for the best part of a year.
So let's walk through the seven mistakes I see most often, and how to avoid every one of them.
Any UK limited company liable for corporation tax can potentially claim, provided it's genuinely attempting to make an advance in science or technology, and facing real technical or scientific uncertainty in doing so — not just uncertainty about whether a project will make money, but genuine uncertainty about whether it's technically achievable at all. This catches far more businesses than people expect. I've worked with a food manufacturer near Paddock Wood who spent months reformulating a recipe to remove an allergen while keeping the taste and shelf life identical — genuine R&D, even though nobody in the business thought of themselves as "doing research." I've also worked with software developers who assumed every line of code they wrote qualified, when in fact most of it was straightforward application of existing, well-understood techniques, which doesn't.
Picture a small engineering firm in Tunbridge Wells developing a new manufacturing process to reduce material waste on a production line, where the outcome genuinely wasn't certain at the outset — would the new tooling actually hold tolerance at scale? That uncertainty, and the systematic work done to resolve it, is exactly the kind of project that qualifies. The relief then effectively reduces the cost of that work, either through a reduction in corporation tax or, for loss-making companies, a cash credit.
In my experience, it's genuinely R&D relief itself. Business owners hear "research and development" and picture lab coats and universities, not the reality — which is that everyday problem-solving in manufacturing, software, engineering, food science, and even certain construction and agricultural innovations can qualify. I'd estimate we identify eligible R&D activity in a meaningful proportion of new clients who came to us never having claimed at all, simply because nobody had ever framed the question properly for them.
Here's one that genuinely surprised me the first time a client asked about it. The "80% rule," sometimes called the "substantially all" rule, is a piece of American IRS guidance — it has nothing to do with HMRC or UK tax law at all. It surfaces constantly in online searches because so much R&D tax content is written for a US audience, and search engines don't always make that distinction obvious. If you've read about an 80% threshold somewhere and assumed it governs your UK claim, that's a mistake worth correcting before it shapes how you approach your figures.
The genuine UK equivalent sits within the Enhanced R&D Intensive Support scheme, or ERIS, aimed at loss-making SMEs. To qualify for this more generous route, your qualifying R&D expenditure needs to represent at least 30% of your total expenditure — a threshold that was actually lowered from 40% to widen access to more companies. It's a completely different figure, testing a completely different thing, from the American 80% rule, and confusing the two can lead a business to either wrongly assume they qualify for enhanced support, or wrongly assume they don't.
R&D tax relief varies enormously between countries — different definitions of qualifying activity, different qualifying costs, different claim mechanisms entirely. A claim built on assumptions borrowed from another jurisdiction's rules is a claim built on sand. I always tell clients: if the guidance you're reading doesn't explicitly reference HMRC, CTA 2009, or the specific UK scheme by name, treat it with real caution.
Broadly, qualifying costs include staff costs for those directly engaged in the R&D (salaries, employer NI, pension contributions), payments to externally provided workers, certain subcontractor costs, consumable items used up in the R&D process, software and, since recent changes, cloud computing and data licence costs directly linked to qualifying R&D activity. Clinical trial volunteer costs qualify too, for businesses in that space.
Yes — R&D relief works alongside, not instead of, the normal deduction you'd already get for these costs as ordinary business expenses. Under the merged scheme, qualifying costs attract an additional taxable credit worth 20% of the expenditure, which either reduces your corporation tax bill or, for companies with no tax liability to offset, can result in a cash payment.
This is really the flip side of the same question — and it's just as important to know what doesn't qualify. Capital expenditure generally falls outside the main R&D relief (though separate capital allowances may apply), as does routine testing, ordinary production, and — crucially — most R&D carried out overseas.
This is one of the biggest changes of the past two years, and one of the most commonly missed. Under the merged scheme, payments to overseas subcontractors and externally provided workers are generally no longer allowable, unless you can demonstrate the R&D genuinely couldn't have been carried out in the UK — not because it was cheaper or more convenient overseas, but because the necessary conditions simply weren't available here. I had a client with a longstanding overseas development partner who was stunned to learn that relationship, entirely legitimate and productive as it was, now fell outside the scope of relief. If any part of your R&D relies on people or subcontractors based outside the UK, this needs reviewing properly before your next claim, not after.
Under the merged scheme, you calculate your total qualifying expenditure, then apply a gross credit rate of 20%. That credit is taxable, meaning the net benefit after corporation tax works out at roughly 15% of qualifying spend for a company paying the main rate — though the exact figure shifts depending on your specific tax position. For loss-making, R&D-intensive SMEs claiming under ERIS instead, the combined effect of the enhanced deduction and payable credit can be worth considerably more, reaching an effective rate of up to 27% of qualifying expenditure.
For accounting periods beginning on or after 1 April 2024, the merged scheme is the default route for the vast majority of companies. ERIS is the exception, reserved specifically for loss-making SMEs whose R&D spend meets that 30% intensity threshold I mentioned above. Getting this choice wrong — claiming through the wrong route, or failing to check whether you now qualify for the more generous ERIS treatment — is a genuinely expensive mistake, and one I see more often than I'd like among businesses managing their own claims without a proper annual review.
For companies seeking a cash payment rather than a reduction in corporation tax, there's a cap: broadly, £20,000 plus three times your total PAYE and NIC liability for the period. This exists specifically to prevent the kind of artificial, low-substance claims that fuelled the original crackdown. If your business has very few employees on payroll relative to the size of your claim, this cap can bite hard, and it's worth modelling in advance rather than discovering it when your payment lands lower than expected.
The standard time limit is two years from the end of the relevant accounting period. That's considerably tighter than the general HMRC assessment time limits we've covered in other guides on this site, and it catches people out constantly — I've had more than one business owner realise, a few weeks too late, that a strong claim from two accounting periods ago had simply expired. If you haven't reviewed your R&D position for a past accounting period recently, it's worth checking the calendar before you assume there's still time.
This one genuinely trips up first-time and returning claimants alike. If you haven't claimed R&D relief in any of the previous three accounting periods, you're now required to submit an Advance Notification Form to HMRC within six months of the end of the accounting period the claim relates to — before you've even finished the year, in many cases. Miss that window, and HMRC can refuse to accept the claim at all, no matter how genuine or well-documented the underlying R&D was. I cannot stress enough how many otherwise strong claims we've seen fall at exactly this hurdle, purely on a procedural technicality that had nothing to do with the quality of the work itself.
Since August 2023, every R&D claim must be accompanied by a detailed Additional Information Form, submitted before the Company Tax Return, setting out the qualifying projects, costs, and the technical case for each. A claim submitted without it is treated as invalid — not delayed, not queried, simply invalid. This isn't a box-ticking formality either; the level of technical and financial detail required is genuinely substantial, and rushing it is one of the fastest routes to a compliance check.
HMRC's published target is to process 85% of claims within 40 days. In practice, for 2026–27, a clean, well-prepared claim under the merged scheme typically takes somewhere in the region of eight to twelve weeks, while ERIS claims often run slightly longer given the additional verification involved for a payable credit. If your claim is selected for a compliance check, though, that timeline changes dramatically — enquiries can run anywhere from six months to well over a year before resolution.
Once HMRC has genuinely approved a claim without further questions, payment typically follows within a few weeks of processing being completed. The real variable isn't the payment itself — it's how long it takes to get to that approved point in the first place, which is precisely why the quality of your initial submission matters so much.
HMRC has been explicit that tackling error and fraud within R&D relief remains a core priority, following years of widespread abuse — much of it driven by contingency-fee advisers who overstated qualifying activity to maximise their own commission rather than the client's genuine entitlement. The result is a scheme with far more upfront scrutiny than it had five years ago: mandatory forms, tighter cost restrictions, and a significantly higher enquiry rate. None of this should discourage a genuine claimant. It simply means the bar for a well-evidenced, properly prepared claim has risen, and cutting corners is a far riskier strategy than it used to be.
The consequences scale with how the error came about. A genuine, reasonable mistake typically results in the claim being adjusted or repaid, sometimes with interest, but without a penalty attached. Where HMRC considers the error careless — a claim prepared without proper care, or based on activity that clearly didn't meet the technical test — penalties of up to 30% of the extra tax involved can apply. Where HMRC believes the claim was deliberately inflated or fabricated, penalties can reach up to 100% of the tax involved, on top of repayment, and in the most serious cases, criminal investigation isn't off the table. This is exactly why the quality and honesty of a claim matters so much more than its size.
You'll receive a formal letter setting out HMRC's concerns, generally with 30 days to respond with supporting evidence — technical reports, timesheets, project documentation, cost breakdowns. Don't panic if this happens; a compliance check doesn't automatically mean your claim is wrong, and plenty of entirely legitimate claims are selected as part of HMRC's wider, deliberately broadened review activity. What matters enormously is responding thoroughly, promptly, and with real substance behind every answer. A rushed or thin response tends to invite further questions rather than closing the matter down.
This is really the thread running through every mistake above: almost all of them are avoidable with proper preparation well before the claim is ever submitted. We work with businesses across Tunbridge Wells and the wider South East to build R&D claims that hold up to scrutiny from day one — reviewing which scheme genuinely applies to you, checking overseas cost exposure, making sure the Advance Notification and Additional Information Forms are filed correctly and on time, and putting together a technical case that actually reflects the real uncertainty your team wrestled with, rather than a generic template stretched to fit.
I'll be candid with you: I'd rather tell a client honestly that a project doesn't quite meet the bar than help them submit something shaky that invites an eighteen-month enquiry. That approach has served our clients well through several years of exactly the kind of tightening scrutiny this guide has described, and it's exactly the approach we'll bring to your claim too.
If you're planning an R&D claim for 2026–27, or reviewing one you've already submitted with fresh eyes, get in touch. We'll help you build a claim you can genuinely stand behind, not just one that ticks the boxes on the day.
Disclaimer:
The content of this blog is for general informational purposes only and should not be considered professional tax advice. The information is correct at the time of publishing but may change following future UK budget announcements or updates to HMRC guidance. Individual circumstances vary, and tax obligations can differ based on your personal situation. We strongly recommend consulting with us or a qualified tax professional to receive advice tailored to your specific needs.
Similar Articles
Newsletter
.svg)
.svg)
